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A 41-year-old female was diagnosed with retinitis pigmentosa (RP) after bilateral implantation of
multifocal intraocular lenses (IOLs). Due to persistent dissatisfaction with her visual performance, she
came to our hospital for medical help. We exchanged the multifocal IOL in the dominant eye with a
monofocal IOL (hybrid monovision therapy), and the visual inconvenience was alleviated to a large
extent. To our knowledge, this is the ﬁrst case report on the effect of hybrid monovision therapy applied
to a patient with RP.
Copyright  2013, The Ophthalmologic Society of Taiwan. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Multifocal intraocular lens (IOL) implantation is now commonly
used because the patient does not need to wear corrective lenses
for near and distant vision after a cataract extraction surgery.
However, some optical adverse effects, such as decreased visual
acuity, halo, and glare, may appear and cause inconvenience in a
patients’ life. Previous studies showed that the dissatisfaction with
bilateral implantation of multifocal IOLs is related to decreased
amplitude and extended peak latency in visual evoked potential
(VEP).1
Retinitis pigmentosa (RP) refers to one group of hereditary
diseases, and its prevalence rate is low. The clinical features include
loss of visual ﬁeld, abnormal electroretinography (ERG), and also
abnormal VEP occasionally. The initial RP may be asymptomatic
and not easy to be diagnosed timely during the examination prior
to cataract surgery. Because both multifocal IOL implantation and
RP exhibit negative effects on VEP, the synergic effect can lead to
more severe photic phenomena if multifocal IOL is implanted in
patients with RP.
A recent study proved that hybrid monovision therapy (the
multifocal IOL in the dominant eye exchanged with a monofocals of interest relevant to this
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e Ophthalmologic Society of TaiwIOL) can increase the amplitude and shorten the latency in VEP,
improving visual performance.1 Nevertheless, previous studies re-
ported only those cases in which clear-type IOLs were used in pa-
tients with normal fundi. No one has reported the application of
this new therapy to patients with abnormal fundi and discussed its
effects on visual performance. We herein present the ﬁrst report on
the application of hybrid monovision therapy to a patient with RP.2. Case report
A 41-year-old female suffered from decreased vision and severe
photic phenomena lasting for more than 3 months after bilateral
implantations with multifocal IOLs (M-ﬂex 630N, Rayner, Hove,
East Sussex, UK). Due to persistent discomfort and inconveniences
in daily life, she came to our hospital for medical help. Prior to
hybrid monovision therapy (after the patient has received multi-
focal IOL implantations for both eyes in another hospital), the
standard ERG of both eyes revealed a normal amplitude and im-
plicit times of the patient’s rod andmaximal responses. The average
value of central multifocal ERG response of the patient was normal,
but that of the peripheral multifocal ERG response was reduced to
35 nV (normal range 71e115 nV). Based on the results of ERG ex-
aminations, the patient was diagnosed with an early-stage RP. The
spherical equivalent (SE) was0.50 in the right eye (dominant eye)
and 1.00 in the left eye (nondominant eye). Her best-corrected
visual acuity was 20/40 in the right eye and 20/40 in the left eye.
The degree of photic phenomena was assessed via a modiﬁed
questionnaire based on the study published by Arnold2 (Table 1)
and visual functions were assessed via a modiﬁed questionnairean. Published by Elsevier Taiwan LLC. All rights reserved.
Table 1
Modiﬁed questionnaire for photic phenomena evaluation.
1. After your eye surgery, did you notice photic phenomena that you had not
noticed prior to surgery?
_ Yes
_ No
If you answered Yes, please answer the following questions.
2. What did your photic phenomena seem the most like? (You may check more
than one.)
_ A curved STREAK of lightdan arc or a semicircle of light, usually seen in
darkness or dim lighting conditions and lasting only for seconds
_ A HALO of lightda circle or a nearly complete circle of light, usually seen in
darkness or dim lighting conditions around a point source of light, such as a
headlight or a streetlight
_ A FLARE of lightda streak or “tail” of light that proceeds consistently from the
same area and goes in the same direction when a point source of light is
viewed
_ A FLASH of lightda very brief spot, splash, or streak of light that maymove and
does not seem to come from a point source of light
_ A GLAREdreduced sharpness of vision in bright lights; may also have halos in
association
_ Other symptoms not mentioned above




4. How severely do these photic phenomena disturb you?
On a scale of 0e4, where 0 is equated with “no daily-life restriction” and 4 with
“extreme daily-life restriction” due to photic phenomena
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Questionnaire-25 (NEI VFQ-25)3 (Table 2).
Considering that the neuroadaptation may take a longer time,
we extended the observation period for another 6 months after the
patient’s ﬁrst visit to our hospital. During the observation period,
complete ophthalmologic examinations were carried out to
exclude dry eye, posterior capsular opacity (PCO), or IOL decen-
tration. Six months later, the patient still suffered from severe vi-
sual inconveniences even when spectacles or contact lenses were
used. Themajor symptoms were decreased visual acuity and severe
photic phenomena, including halo, glare, ﬂare, and double vision.
Day- and night-time life functions were strictly limited. In our
clinical experiences, the symptoms of this patient were much more
severe than other cases with normal fundi.
We applied hybrid monovision therapy and exchanged the IOL
in the dominant eye with an UV-light-ﬁltering monofocal foldable
lens (aspheric monofocal IOL, ZCB00, AMO, Milpitas, CA, USA). The
IOL power was selected for distance visual acuity (0.00 D). Three
months after the hybrid monovision therapy, ophthalmologic ex-
aminations were performed. No postoperative complication was
noted. Spherical equivalent of the dominant eye was 0.05 and its
best-corrected visual acuity increased to 20/30. Halo disappeared
completely. The glare and ﬂare were improved from a score of 4 to
that of 2. The double vision scores improved from 4 to 2.
The differences in vision prior to and after the hybrid mono-
vision therapy are evaluated more speciﬁcally as follows. Prior to
the operation, double vision was signiﬁcant when the distance of
the objective was greater than 10 m at day and 5 m at night. AfterTable 2
Modiﬁed questionnaire for visual function evaluation.
1. How much difﬁculty do you have reading ordinary print in newspapers?
(0 ¼ none, 4 ¼ extreme)
2. Howmuch difﬁculty do you have in seeing objects close to you in poor or dim
light? (0 ¼ none, 4 ¼ extreme)
3. How much difﬁculty do you have driving during the daytime? (0 ¼ none,
4 ¼ extreme)
4. How much difﬁculty do you have driving at night? (0 ¼ none, 4 ¼ extreme)
5. At present, would you say your eyesight using both eyes (with glasses or
contact lenses, if you wear them) is excellent, good, fair, poor, or very poor or
are you completely blind? (0 ¼ excellent, 4 ¼ very poor)the operation, the symptom was noted only when the distance of
the objective was more than 60 m at day and 15 m at night. Prior to
the therapy, the results of visual functional evaluations indicated
that the patient was able to read only the title of a newspaper in a
high-illumination condition. After the therapy, because the power
of the monofocal IOL was selected for distance visual acuity, the
patient had to wear spectacles to read; however, she could now
read small-print texts in newspapers with near-refractive correc-
tion. The patient could also recognize objects passing through the
space in a dim light condition, which shewas not capable of prior to
the operation. Therefore, driving at daytime became safe enough
after the operation because the patient could now recognize trafﬁc
lights and vehicles clearly. However, it was still too dangerous for
the patient to drive at night.
3. Discussion
Neuroadaptation, which takes usually about 6 months, is a key
factor for multifocal IOL implantation.4 However, visual outcomes
after multifocal IOL implantation can be inﬂuenced bymany factors
other than neuroadaptation, such as ametropia, dry eye syndrome,
PCO, and retained lens fragments.5,6 These problems can be
resolved by refractive surgery, spectacles, artiﬁcial tears, or laser
capsulotomy. If the visual inconvenience cannot be improved
effectively by these noninvasive or minimal invasive methods, IOL
exchange may be considered.
In this case, we believe that the severe visual dissatisfactionwas
related to the mechanism of a multifocal IOL and the retinal pho-
toreceptors. A multifocal IOL is designed to create near and far foci
simultaneously. Multifocal IOLs are primarily of two types: dif-
fractive and refractive types.7 The diffractive type is near dominant
and associated with about 18e20% light transmission loss. Light
distribution is approximately 70% at a near distance and 30% at a far
distance.8 The refractive type is distant dominant and has no light
transmission loss. Light distribution is 70% at a far distance and 30%
at a near distance.9 In short, for patients undergoing either dif-
fractive- or refractive-type multifocal IOL implantation, light-
sensing cells of the retina do not receive 100% light from the sub-
ject at any distance.
Second, as mentioned earlier, previous studies have shown that
the dissatisfaction after bilateral implantation of a multifocal IOL is
related to a decreased amplitude and extended peak latency in
VEP.1 Moreover, if the patient had defective retinal cells, VEP
stimulation would be worse than in those with normal cells. The
combination of these two factors may have caused serious visual
symptoms in this patient.
After the monofocal IOL exchange in the dominant eye, the light
converges to one focus and no loss in intensity occurs, causing
stronger photostimulation to retinal cells. Furthermore, because of
the decrease of complexity in the dominant eye, the photic phe-
nomena were much more improved and the degree of interocular
suppression also decreased. These synergic factors brought signif-
icant improvement in visual performances. In this case, we
measured the P100 amplitude and peak latency in VEP examina-
tions. After the operation, the amplitude in the dominant eye
increased from 7.1 mV (preoperation) to 10.9 mV (postoperation) and
that in the nondominant eye increased from 6.9 mV to 7.5 mV. The
peak latency in the dominant eye improved from 148 ms to 121 ms
and that in the nondominant eye improved from 149 ms to 139 ms.
The improvement percentage in the P100 amplitude of the domi-
nant eye is six times better than that of the nondominant eye, and
that in the peak latency of the dominant eye is almost three times
better than that of the nondominant eye.
IOL exchange is a higher-risk method in dealing with the
dissatisfaction after multifocal IOL implantation.10e13 The status of
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PCO can disrupt the optical properties of a multifocal IOL and cause
light scattering. Therefore, Nd:YAG (neodymium-doped yttrium
aluminum garnet) capsulotomy is often used to remove opacity
from the visual axis. Nevertheless, the broken capsule may increase
the intraoperative risk, e.g., vitreous prolapse, in IOL exchange, and
in case of such conditions, anterior vitrectomy would become
necessary, causing a longer operation time and higher infection
rate.10 Therefore, it is very important to ensure whether PCO is the
source of dissatisfaction prior to performing an IOL exchange.
Furthermore, if hybrid monovision therapy is to be applied to pa-
tients who suffer from discomfort after bilateral implantations of
multifocal IOLs, proper evaluations need to be performed to decide
which eye should be exchanged to offer more advantages.
In our case, the hybrid monovision therapy was very effective in
improving the visual functions of the patient with abnormal fundi.
We hope our report can provide useful information to other
ophthalmologists.
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